Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Discontinuing clopidogrel before abdominal operation — whether elective or emergent — may not be necessary, a New York team advises. When discontinuation is…
NEW YORK (Reuters Health) – Screening pregnant women for chlamydia using urine samples is just as accurate as when cervical secretions are used, suggests a new study published…
NEW YORK (Reuters Health) – Hydrocortisone therapy may lower the risk of nosocomial pneumonia in severe trauma patients, according to new research from France. The study also found…
NEW YORK (Reuters Health) – A coronary artery bypass graft (CABG) is the best choice for patients with multivessel coronary artery disease who are also diabetic, according to…
NEW YORK (Reuters Health) – Contrary to prior assumptions, prolongation of atrioventricular conduction in fetuses exposed to maternal anti-Ro antibodies does not predict progression to complete atrioventricular block…
NEW YORK (Reuters Health) – For abortion in the second trimester performed for fetal anomalies or fetal death, dilation and evacuation (D&E) is considerably safer than the labor-induction…
NEW YORK (Reuter Health) – With the availability of more sensitive troponin I assays, lowering the diagnostic threshold for detection of myocardial necrosis from 0.20 to 0.05 ng/mL…
NEW YORK (Reuters Health) – Inflammatory bowel disease (IBD) activity is an independent risk factor for the development of venous thromboembolic events (VTEs). That’s one of the findings…
NEW YORK (Reuters Health) – A coronary stent incorporating a polytetrafluoroethylene membrane does not live up to expectations in the treatment of diseased aortocoronary saphenous vein grafts, investigators…
NEW YORK (Reuters Health) – Although prophylactic intravenous immune globulin (IVIg) is recommended for neonates with rhesus hemolytic disease, it does not improve outcomes or lessen the need…
